Cancer Family
Genitourinary System Neoplasm
CI-CAN-00000018Explore in graph →
Non-malignant3,846 active trials61 approved drugs306 evidence items
- NCIt
- C156482
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000018Explore in graph →
Clinical trials
17,382 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00002503 | Strontium Compared With Radiation Therapy in Treating Patients With Hormone-Refractory Prostate Cancer With Painful Bone Metastases | completed | Phase 3 | 204 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Sep 24, 2012 | clinicaltrials |
| NCT00003941 | Combination Chemotherapy With or Without Peripheral Stem Cell Transplant in Treating Men With Previously Untreated Germ Cell Cancer | completed | Phase 3 | 222 | European Organisation for Research and Treatment of Cancer - EORTC |
| 12 |
| Sep 24, 2012 |
| clinicaltrials |
| NCT00006356 | Chemotherapy With or Without Surgery in Treating Patients With Recurrent Ovarian Cancer | terminated | Phase 3 | 38 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00014586 | Bicalutamide Compared With Observation Followed by Bicalutamide Plus Either Goserelin or Orchiectomy in Treating Patients With Prostate Cancer | terminated | Phase 3 | 110 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Sep 24, 2012 | clinicaltrials |
| NCT00042887 | Chemotherapy With or Without Surgery in Treating Patients With Bladder Cancer | terminated | Phase 3 | 58 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 5 | Sep 24, 2012 | clinicaltrials |
| NCT00053807 | Interleukin-2, Interferon Alfa, and Fluorouracil Compared With Observation in Treating Patients Who Have Undergone Surgery for Kidney Cancer | completed | Phase 3 | 96 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Sep 24, 2012 | clinicaltrials |
| NCT00316706 | Human Papilloma Virus (HPV) Vaccine Trial in Young Adolescent Women With GlaxoSmithKline Biologicals' (GSK Bio) HPV-16/18 Vaccine | completed | Phase 3 | 1,245 | GlaxoSmithKlineINDUSTRY | 5 | Sep 18, 2012 | clinicaltrials |
| NCT00004071 | Mitoxantrone and Prednisone With or Without Leflunomide in Treating Patients With Stage IV Prostate Cancer | completed | Phase 2 / Phase 3 | — | PfizerINDUSTRY | 1 | Sep 11, 2012 | clinicaltrials |
| NCT00617669 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) and Docetaxel in Metastatic Hormone Resistant Prostate Cancer(ENTHUSE M1C) | completed | Phase 3 | 1,494 | AstraZenecaINDUSTRY | 26 | Sep 10, 2012 | clinicaltrials |
| NCT00033904 | Survival Study Of Oncophage® vs. Observation In Patients With Kidney Cancer | completed | Phase 3 | 650 | Agenus Inc.INDUSTRY | 11 | Sep 7, 2012 | clinicaltrials |
| NCT00126178 | Clinical Trial Studying a Personalized Cancer Vaccine in Patients With Non-metastatic Kidney Cancer | terminated | Phase 3 | 600 | Agenus Inc.INDUSTRY | 2 | Sep 7, 2012 | clinicaltrials |
| NCT00626548 | A Phase III Trial of ZD4054 (Zibotentan) (Endothelin A Antagonist) in Non-metastatic Hormone Resistant Prostate Cancer(ENTHUSE M0) | terminated | Phase 3 | 2,577 | AstraZenecaINDUSTRY | 39 | Sep 3, 2012 | clinicaltrials |
| NCT00450970 | Expanded Access Study of Satraplatin Plus Prednisone in Patients With Hormone Refractory Prostate Cancer (HRPC)(SPERA) | terminated | Phase 3 | 344 | AgennixINDUSTRY | 1 | Aug 17, 2012 | clinicaltrials |
| NCT00978718 | Selenium in Preventing Prostate Cancer | completed | Phase 3 | 700 | University of ArizonaOTHER | 0 | Aug 15, 2012 | clinicaltrials |
| NCT00003343 | Chemotherapy in Treating Patients Who Have Metastatic Prostate Cancer | completed | Phase 3 | 525 | PfizerINDUSTRY | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00388804 | External Beam Radiation Therapy (EBRT) With or Without Hormonal Therapy in Prostate Cancer | terminated | Phase 3 | 39 | M.D. Anderson Cancer CenterOTHER | 1 | Aug 8, 2012 | clinicaltrials |
| NCT00069745 | Satraplatin in Hormone Refractory Prostate Cancer Patients Previously Treated With One Cytotoxic Chemotherapy Regimen | completed | Phase 3 | — | AgennixINDUSTRY | 15 | Aug 7, 2012 | clinicaltrials |
| NCT01654146 | ICON8: Weekly Chemotherapy in Ovarian Cancer(ICON8) | unknown | Phase 3 | 1,485 | Medical Research CouncilOTHER_GOV | 1 | Jul 31, 2012 | clinicaltrials |
| NCT00502723 | Multicentric Study Comparing Carcinological and Functional Results of Surgery(PROPENLAP) | unknown | Phase 3 | 1,440 | Assistance Publique - Hôpitaux de ParisOTHER | 1 | Jul 30, 2012 | clinicaltrials |
| NCT00002737 | Interferon Alfa With or Without Isotretinoin in Treating Patients With Metastatic Kidney Cancer | completed | Phase 3 | 320 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 9 | Jul 11, 2012 | clinicaltrials |
| NCT00002764 | Surgery With or Without Combination Chemotherapy in Treating Patients With Lung Metastases From Soft Tissue Sarcoma | completed | Phase 3 | 340 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00003209 | Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer | completed | Phase 3 | 700 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 1 | Jul 11, 2012 | clinicaltrials |
| NCT00003267 | Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer | completed | Phase 3 | 214 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 8 | Jul 11, 2012 | clinicaltrials |
| NCT00849082 | Radiation Therapy With or Without Goserelin and Cyproterone in Treating Patients With Prostate Cancer | completed | Phase 3 | — | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 0 | Jul 11, 2012 | clinicaltrials |
| NCT00436839 | Taxotere Prostate Cancer New Indication Registration Trial in China | completed | Phase 3 | 228 | SanofiINDUSTRY | 1 | Jul 9, 2012 | clinicaltrials |
| NCT00003026 | Hormone Therapy in Treating Patients With Advanced Prostate Cancer | completed | Phase 3 | 966 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 7 | Jul 2, 2012 | clinicaltrials |
| NCT00127387 | Enbrel Versus Placebo With Radiation Therapy to Combat Fatigue and Cachexia | terminated | Phase 2 / Phase 3 | 54 | The University of Texas Health Science Center at San AntonioOTHER | 1 | Jun 26, 2012 | clinicaltrials |
| NCT00520546 | Clinical Value of FEC-PET Combined With Endorectal MRI for Pre-therapeutic Staging of Prostate Cancer(FEC-PET/MRI) | completed | Phase 3 | 44 | Dr. Markus HartenbachOTHER | 1 | Jun 20, 2012 | clinicaltrials |
| NCT00057928 | S0227 Cisplatin With Either Paclitaxel or Gemcitabine in Recurrent, Persistent, or Metastatic Cervical Cancer | withdrawn | Phase 3 | 0 | SWOG Cancer Research NetworkNETWORK | 2 | Jun 13, 2012 | clinicaltrials |
| NCT00004166 | Amifostine in Treating Patients With Ovarian Epithelial Cancer Who Are Receiving Chemotherapy | completed | Phase 3 | — | Northwestern UniversityOTHER | 1 | Jun 6, 2012 | clinicaltrials |
| NCT00102973 | TLK286 (Telcyta) in Combination With Carboplatin (Paraplatin) Versus Doxil in Platinum Refractory or Resistant Ovarian Cancer | completed | Phase 3 | 244 | TelikINDUSTRY | 1 | May 31, 2012 | clinicaltrials |
| NCT00237575 | Randomized Phase III Trial of Leukine® vs Neupogen® in Patients Receiving Cisplatin & Gemcitabine for Urothelial Cancer | terminated | Phase 3 | 100 | University of KentuckyOTHER | 1 | May 23, 2012 | clinicaltrials |
| NCT01542567 | Efficacy of Diclofenac BCG Irrigations(DIC-2011) | unknown | Phase 3 | 100 | Carmel Medical CenterOTHER | 0 | May 22, 2012 | clinicaltrials |
| NCT00311467 | Combined Treatment With Capecitabine and Immunotherapy Versus Immunotherapy Alone in Advanced Renal Cell Carcinoma | terminated | Phase 3 | 172 | Central European Cooperative Oncology GroupOTHER | 1 | May 16, 2012 | clinicaltrials |
| NCT00294437 | ZOMETA® (Zoledronic Acid) for Prevention of Bone Metastases | terminated | Phase 3 | 376 | Central European Cooperative Oncology GroupOTHER | 16 | May 1, 2012 | clinicaltrials |
| NCT00911027 | SonoVue Guided Prostate Biopsy | terminated | Phase 3 | 282 | Bracco Diagnostics, IncINDUSTRY | 7 | Apr 25, 2012 | clinicaltrials |
| NCT01367418 | Effects of Anesthetic Technique on Immune and Inflammatory Systems Following Radical Prostatectomy(AIMS) | completed | Phase 3 | 26 | Örebro University, SwedenOTHER | 1 | Mar 19, 2012 | clinicaltrials |
| NCT00003824 | S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer | terminated | Phase 3 | 114 | SWOG Cancer Research NetworkNETWORK | 1 | Mar 9, 2012 | clinicaltrials |
| NCT00003643 | Combination Chemotherapy in Treating Men With Germ Cell Cancer | unknown | Phase 2 / Phase 3 | 498 | European Organisation for Research and Treatment of Cancer - EORTCNETWORK | 14 | Mar 6, 2012 | clinicaltrials |
| NCT00177125 | Evaluating the Effect of the VCD on Erectile Function and Penile Length Post RRP | completed | Phase 3 | 220 | University of MinnesotaOTHER | 1 | Feb 6, 2012 | clinicaltrials |
| NCT00426777 | Efficacy Study of Risedronate to Prevent Cancer Treatment-Induced Bone Loss in Prostate Cancer | completed | Phase 3 | 160 | CMX ResearchOTHER | 1 | Feb 3, 2012 | clinicaltrials |
| NCT00243685 | Chemotherapy Drug Sensitivity Microculture (MiCK) Assay for Apoptosis | completed | Phase 2 / Phase 3 | 150 | Pierian BiosciencesINDUSTRY | 1 | Jan 26, 2012 | clinicaltrials |
| NCT00283062 | Adjuvant Leuprolide With or Without Docetaxel in High Risk Prostate Cancer After Radical Prostatectomy | completed | Phase 3 | 228 | SanofiINDUSTRY | 17 | Jan 26, 2012 | clinicaltrials |
| NCT00245050 | Pyridoxine in Preventing Hand-Foot Syndrome in Patients Who Are Receiving Liposomal Doxorubicin for Cancer | completed | Phase 3 | 34 | Case Comprehensive Cancer CenterOTHER | 1 | Dec 30, 2011 | clinicaltrials |
| NCT00418574 | Efficacy Multicentre Trial of ImmunoTherapy Vaccination With Abagovomab to Treat Ovarian Cancer Patients(MIMOSA) | terminated | Phase 2 / Phase 3 | 888 | Menarini GroupINDUSTRY | 9 | Nov 24, 2011 | clinicaltrials |
| NCT01474356 | Hyperthermia Combined Brachytherapy in CCU | completed | Phase 3 | 224 | Maria Sklodowska-Curie National Research Institute of OncologyOTHER | 1 | Nov 18, 2011 | clinicaltrials |
| NCT00122746 | Clinical and Experimental Studies to Improve Radiotherapy Outcome in AIDS Cancer Patients | unknown | Phase 3 | 322 | International Atomic Energy AgencyOTHER_GOV | 5 | Oct 13, 2011 | clinicaltrials |
| NCT00622973 | USPIO-enhanced and Diffusion-weighted MRI for the Detection of Pelvic Lymph Node Metastases | completed | Phase 3 | 130 | Insel Gruppe AG, University Hospital BernOTHER | 1 | Oct 12, 2011 | clinicaltrials |
| NCT01149174 | Preoperative Intravesical Electromotive Mitomycin-c for Primary Non-muscle Invasive Bladder Cancer(EMDA/PRE-TUR) | completed | Phase 3 | 352 | University of Rome Tor VergataOTHER | 1 | Oct 4, 2011 | clinicaltrials |
| NCT01442519 | Sequential Bacillus Calmette-Guérin (BCG) and Electromotive Mitomycin-C Versus Bacillus Calmette-Guérin (BCG) Alone for High Risk Superficial Bladder Cancer(BCG/EMDA-MMC) | completed | Phase 3 | 212 | University of Rome Tor VergataOTHER | 1 | Sep 28, 2011 | clinicaltrials |
Data updated 23 days agoSource updated Sep 24, 2012source: clinicaltrials